Hemorrhagic Fever News and Research

RSS
Viral hemorrhagic fevers (VHFs) refer to a group of illnesses that are caused by several distinct families of viruses. In general, the term "viral hemorrhagic fever" is used to describe a severe multisystem syndrome (multisystem in that multiple organ systems in the body are affected). Characteristically, the overall vascular system is damaged, and the body's ability to regulate itself is impaired. These symptoms are often accompanied by hemorrhage (bleeding); however, the bleeding is itself rarely life-threatening. While some types of hemorrhagic fever viruses can cause relatively mild illnesses, many of these viruses cause severe, life-threatening disease.
World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

World's most clinically advanced dengue vaccine candidate enters first phase 3 clinical study

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

Paragon Bioservices awarded contract to assist USAMRIID in vaccine development efforts

NanoViricides files financial year end annual report with SEC

NanoViricides files financial year end annual report with SEC

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Inviragen, PharmaJet awarded NIAID contract to develop needle-free, easy to administer dengue vaccine

Dengue fever vaccine in the pipeline

Dengue fever vaccine in the pipeline

Media reporting can reduce impact of infectious disease outbreaks

Media reporting can reduce impact of infectious disease outbreaks

Numerate awarded new contract by Defense Threat Reduction Agency

Numerate awarded new contract by Defense Threat Reduction Agency

New antisense drugs may help treat accidental infections: Study

New antisense drugs may help treat accidental infections: Study

NIH begins human clinical testing for dengue virus vaccine

NIH begins human clinical testing for dengue virus vaccine

Dengue fever emerges as major health threat in Gulf coast cities

Dengue fever emerges as major health threat in Gulf coast cities

NanoViricides presents study results of nanoviricides anti-Ebola agents

NanoViricides presents study results of nanoviricides anti-Ebola agents

Update on suspected Acute Haemorrhagic Fever in Republic of the Congo

Update on suspected Acute Haemorrhagic Fever in Republic of the Congo

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

Successful growth of mouse embryonic stem cells in rat lungs raises hopes for engineering human transplants

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

NanoViricides' anti-Dengue drug candidates demonstrate potential against severe virus infection

Experimental vaccine for Marburg hemorrhagic fever prevention shows promise for accidental exposures

Experimental vaccine for Marburg hemorrhagic fever prevention shows promise for accidental exposures

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Anti-Dengue drug candidates demonstrate efficacy in preliminary cell culture studies

Study demonstrates protection against Ebola infection in nonhuman primates using RNAi

Study demonstrates protection against Ebola infection in nonhuman primates using RNAi

Saint Louis University conducts research to find safe, effective vaccination for dengue

Saint Louis University conducts research to find safe, effective vaccination for dengue

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

Inviragen initiates first clinical trial of DENVax vaccine to protect against dengue fever

New study may help design better vaccines for dengue fever

New study may help design better vaccines for dengue fever

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.